These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33013387)

  • 1. PKM2-c-Myc-Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer.
    Yu P; Li AX; Chen XS; Tian M; Wang HY; Wang XL; Zhang Y; Wang KS; Cheng Y
    Front Pharmacol; 2020; 11():550469. PubMed ID: 33013387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAMPT regulates PKM2 nuclear location through 14-3-3ζ: Conferring resistance to tamoxifen in breast cancer.
    Ge X; Zhao Y; Dong L; Seng J; Zhang X; Dou D
    J Cell Physiol; 2019 Dec; 234(12):23409-23420. PubMed ID: 31141164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer.
    Qian Y; Bi L; Yang Y; Wang D
    Anticancer Drugs; 2018 Aug; 29(7):616-627. PubMed ID: 29782350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells.
    Kim S; Jeon M; Lee JE; Nam SJ
    Oncol Rep; 2016 Apr; 35(4):2398-404. PubMed ID: 26780941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells.
    Lee MH; Koh D; Na H; Ka NL; Kim S; Kim HJ; Hong S; Shin YK; Seong JK; Lee MO
    Autophagy; 2018; 14(5):812-824. PubMed ID: 29130361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte Proliferation.
    Liu YZ; Xu MY; Dai XY; Yan L; Li L; Zhu RZ; Ren LJ; Zhang JQ; Zhang XF; Li JF; Tian YJ; Shi WJ; Liu YQ; Jiang CL; Zhu JB; Chen JK
    Front Pharmacol; 2021; 12():765790. PubMed ID: 34733164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate kinase M2 interacts with mammalian sterile 20-like kinase 1 and inhibits tamoxifen-induced apoptosis in human breast cancer cells.
    Ji F; Guo B; Wang N; Zhong C; Huang L; Huang Y; Wei L; Su M; Jiang Y; Jin Q; Liu Y; Zhang Z; Yang J; Chen T
    Tumour Biol; 2017 Apr; 39(4):1010428317692251. PubMed ID: 28656802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
    Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells.
    Campbell PS; Mavingire N; Khan S; Rowland LK; Wooten JV; Opoku-Agyeman A; Guevara A; Soto U; Cavalli F; Loaiza-Pérez AI; Nagaraj G; Denham LJ; Adeoye O; Jenkins BD; Davis MB; Schiff R; Brantley EJ
    J Cell Physiol; 2018 Jan; 234(1):108-121. PubMed ID: 30076704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
    Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer.
    Thuy Phuong NT; Kim JW; Kim JA; Jeon JS; Lee JY; Xu WJ; Yang JW; Kim SK; Kang KW
    Oncotarget; 2017 Sep; 8(41):71054-71069. PubMed ID: 29050342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2.
    Jiang K; He B; Lai L; Chen Q; Liu Y; Guo Q; Wang Q
    Int J Mol Med; 2012 Aug; 30(2):302-8. PubMed ID: 22580449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
    Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
    J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
    Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
    Vaziri-Gohar A; Zheng Y; Houston KD
    Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.